Search Results - "Vaz, Frédéric M."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors by Arends, Maarten, Biegstraaten, Marieke, Hughes, Derralynn A, Mehta, Atul, Elliott, Perry M, Oder, Daniel, Watkinson, Oliver T, Vaz, Frédéric M, van Kuilenburg, André B P, Wanner, Christoph, Hollak, Carla E M

    Published in PloS one (01-08-2017)
    “…Despite enzyme replacement therapy, disease progression is observed in patients with Fabry disease. Identification of factors that predict disease progression…”
    Get full text
    Journal Article
  5. 5

    Peroxisomes can oxidize medium‐ and long‐chain fatty acids through a pathway involving ABCD3 and HSD17B4 by Violante, Sara, Achetib, Nihad, Roermund, Carlo W. T., Hagen, Jacob, Dodatko, Tetyana, Vaz, Frédéric M., Waterham, Hans R., Chen, Hongjie, Baes, Myriam, Yu, Chunli, Argmann, Carmen A., Houten, Sander M.

    Published in The FASEB journal (01-03-2019)
    “…ABSTRACT Peroxisomes are essential organelles for the specialized oxidation of a wide variety of fatty acids, but they are also able to degrade fatty acids…”
    Get full text
    Journal Article
  6. 6

    Bactericidal activity of amphipathic cationic antimicrobial peptides involves altering the membrane fluidity when interacting with the phospholipid bilayer by Omardien, Soraya, Drijfhout, Jan W., Vaz, Frédéric M., Wenzel, Michaela, Hamoen, Leendert W., Zaat, Sebastian A.J., Brul, Stanley

    “…Amphipathic cationic antimicrobial peptides (AMPs) TC19 and TC84, derived from the major AMPs of human blood platelets, thrombocidins, and Bactericidal Peptide…”
    Get full text
    Journal Article
  7. 7

    Inherited disorders of complex lipid metabolism: A clinical review by Xiao, Changrui, Rossignol, Francis, Vaz, Frédéric M., Ferreira, Carlos R.

    Published in Journal of inherited metabolic disease (01-07-2021)
    “…Over 80 human diseases have been attributed to defects in complex lipid metabolism. A majority of them have been reported recently in the setting of rapid…”
    Get full text
    Journal Article
  8. 8

    Fatty Acid Oxidation in Peroxisomes: Enzymology, Metabolic Crosstalk with Other Organelles and Peroxisomal Disorders by Wanders, Ronald J A, Vaz, Frédéric M, Waterham, Hans R, Ferdinandusse, Sacha

    “…Peroxisomes play a central role in metabolism as exemplified by the fact that many genetic disorders in humans have been identified through the years in which…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Enzymology of the carnitine biosynthesis pathway by Strijbis, Karin, Vaz, Frédéric M., Distel, Ben

    Published in IUBMB life (01-05-2010)
    “…The water‐soluble zwitterion carnitine is an essential metabolite in eukaryotes required for fatty acid oxidation as it functions as a carrier during transfer…”
    Get full text
    Journal Article
  11. 11

    Aging selectively dampens oscillation of lipid abundance in white and brown adipose tissue by Held, Ntsiki M., Buijink, M. Renate, Elfrink, Hyung L., Kooijman, Sander, Janssens, Georges E., Luyf, Angela C. M., Pras-Raves, Mia L., Vaz, Frédéric M., Michel, Stephan, Houtkooper, Riekelt H., van Weeghel, Michel

    Published in Scientific reports (15-03-2021)
    “…Lipid metabolism is under the control of the circadian system and circadian dysregulation has been linked to obesity and dyslipidemia. These factors and…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Cardiolipin provides an essential activating platform for caspase-8 on mitochondria by Gonzalvez, Francois, Schug, Zachary T, Houtkooper, Riekelt H, MacKenzie, Elaine D, Brooks, David G, Wanders, Ronald J.A, Petit, Patrice X, Vaz, Frédéric M, Gottlieb, Eyal

    Published in The Journal of cell biology (17-11-2008)
    “…Cardiolipin is a mitochondria-specific phospholipid known to be intimately involved with apoptosis. However, the lack of appropriate cellular models to date…”
    Get full text
    Journal Article
  14. 14

    Disorders of fatty acid homeostasis by Vaz, Frédéric M, Ferdinandusse, Sacha, Salomons, Gajja S, Wanders, Ronald J A

    Published in Journal of inherited metabolic disease (01-05-2024)
    “…Humans derive fatty acids (FA) from exogenous dietary sources and/or endogenous synthesis from acetyl-CoA, although some FA are solely derived from exogenous…”
    Get full text
    Journal Article
  15. 15

    C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man by van de Beek, Malu-Clair, Dijkstra, Inge M E, van Lenthe, Henk, Ofman, Rob, Goldhaber-Pasillas, Dalia, Schauer, Nicolas, Schackmann, Martin, Engelen-Lee, Joo-Yeon, Vaz, Frédéric M, Kulik, Wim, Wanders, Ronald J A, Engelen, Marc, Kemp, Stephan

    Published in PloS one (28-04-2016)
    “…X-linked adrenoleukodystrophy (ALD), a progressive neurodegenerative disease, is caused by mutations in ABCD1 and characterized by very-long-chain fatty acids…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Cardiac lipidomic profiles in mice undergo changes from fetus to adult by Chen, Ze'e, Pan, Zhixiang, Huang, Can, Zhu, Xiangbin, Li, Na, Huynh, Helen, Xu, Junjie, Huang, Lei, Vaz, Frédéric M., Liu, Jie, Han, Zhen, Ouyang, Kunfu

    Published in Life sciences (1973) (15-03-2024)
    “…Lipids are essential cellular components with many important biological functions. Disturbed lipid biosynthesis and metabolism has been shown to cause cardiac…”
    Get full text
    Journal Article
  20. 20

    Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER by Thompson, William R., Manuel, Ryan, Abbruscato, Anthony, Carr, Jim, Campbell, John, Hornby, Brittany, Vaz, Frédéric M., Vernon, Hilary J.

    Published in Genetics in medicine (01-07-2024)
    “…Evaluate long-term efficacy and safety of elamipretide during the open-label extension (OLE) of the TAZPOWER trial in individuals with Barth syndrome (BTHS)…”
    Get full text
    Journal Article